Emcure pharmaceuticals limited valuation
WebJan 6, 2024 · What is the revenue of Emcure Pharmaceuticals? What is the valuation of Emcure Pharmaceuticals? The leading pharma company, Emcure Pharmaceuticals has an estimated valuation of Rs 5000 crores. WebInformation on valuation, funding, acquisitions, investors, and executives for Emcure. Use the PitchBook Platform to explore the full profile.
Emcure pharmaceuticals limited valuation
Did you know?
WebApply for Emcure Pharma IPO – Get the Latest News & Subscription Status including bidding dates and more details. Start Investing in Emcure Pharma IPO Online with Angel … WebAug 19, 2024 · Emcure Pharmaceuticals Limited, headquartered in Pune has submitted Draft Red Herring Prospectus(DRHP) to Securities and Exchange Board of India(SEBI) …
WebDec 13, 2024 · Get details like Emcure Pharma IPO GMP, review, price, listing date, timetable, allotment, financials, subscription, broker view, peer comparison. WebMr. Vikas Thapar President, Corporate Development, Strategy & Finance. Mr. Sanjay Mehta President, Emerging Markets. Mr. Tajuddin Shaikh Chief Financial Officer. Mr. Prakash Guha Managing Director (MD) - Zuventus Healthcare Limited. Dr. Deepak Gondaliya President – Technical Operations. Dr. Sanjay Singh Chief Executive Officer & Whole-time ...
WebMar 6, 2024 · $1.1B 2024 Billionaires Net Worth as of 3/6/18 Photo by Shyam Sonar/The Times Of India Group About Satish Mehta Pharma distributor's son Satish Mehta founded and runs privately held generics maker... WebJan 15, 2024 · Promoters own 85.41% stake in Emcure, while Bain holds 13.09% and balance 1.50% is held by key employees and associates. On a provisional basis, for the first six months of fiscal 2024, revenue was Rs 2803 crore and PAT was Rs 191 crore against Rs 2426 crore of revenue and Rs 12.47 crore of PAT in corresponding period of last fiscal.
WebAug 19, 2024 · Emcure Pharmaceuticals Limited, headquartered in Pune has submitted Draft Red Herring Prospectus (DRHP) to Securities and Exchange Board of India (SEBI) for initial public offering (IPO) of INR 1,100 crore value equity shares & 18,168,356 equity shares on 18 August 2024.
WebAug 19, 2024 · Emcure Pharmaceuticals Limited has filed its draft IPO (Initial Public Offering) papers with capital markets regulator SEBI. The company is looking to raise … slb ithriveBain-backed Emcure Pharmaceuticals eyes $672 mln IPO - source. By Aditi Shah. BENGALURU, Aug 19 (Reuters) - India's Emcure Pharmaceuticals has filed draft papers with the market regulator for an ... slb investments llcWebEmcure believes in success through innovation and its other core values such as Integrity, Patient & Quality Focus, Team work, Respect and Value Driven. We believe that people are key differentiators and hence, there is an emphasis on hiring, engaging, motivating, retaining and developing the right talent for the right role in the right way. slb investor relations newsWebJan 20, 2024 · Emcure is one of the market leaders in HIV antivirals, gynaecology and blood-related therapeutic areas, and had a domestic market share of 51.53 per cent, 11.85 per cent and 10.26 per cent ... slb inthinc kioskWebJan 20, 2024 · Its products are available across 70 countries, barring the US, which it exited a few years ago. Emcure reported revenue of Rs 6,091.8 crore in FY21, Rs 5,130.8 … slb knowledge baseWebJan 20, 2024 · Mumbai: Emcure Pharmaceuticals has received regulatory approvals for its draft red herring prospectus and will shortly be filing the RHP for the Rs 5,000-crore … slb leagueWebMs. Namita Thapar joined Emcure as CFO, post her 6-year stint at Guidant Corporation, USA, subsequently her responsibilities grew to managing Emcure’s largest business unit, the India Business. Ms. Thapar is passionate about improving women’s health in India and promoting youth entrepreneurship. During the Covid pandemic, she launched a ... slb leasing